Forwarded "The General Department of the State Drug Administration publicly solicits opinions on the "Notice on the Release of the "Good Manufacturing Practice for Pharmaceutical Excipients" and "Good Manufacturing Practice for Pharmaceutical Packaging Ma
Forward "The General Department of the National Medical Products Administration publicly solicits opinions on the "Notice on the Release of the 'Good Manufacturing Practice for Pharmaceutical Excipients' and 'Good Manufacturing Practice for Pharmaceutical Packaging Materials' (Draft for Solicitation of Comments)"
In order to implement the relevant requirements of the "Drug Administration Law" and the "Drug Production Supervision and Administration Measures" and improve the production management quality of pharmaceutical excipients and pharmaceutical packaging materials, the National Medical Products Administration organized the drafting of the "Notice on the Release of the 'Good Manufacturing Practice for Pharmaceutical Excipients' and 'Good Manufacturing Practice for Pharmaceutical Packaging Materials' (Draft for Solicitation of Comments)", and now publicly solicits opinions from the society.
Please feedback the relevant opinions in accordance with the format requirements of the "Feedback Form" to the email address yaopinjianguan-2@nmpa.gov.cn before August 20, 2024. Please indicate "Feedback on GMP for Pharmaceutical Excipients and Pharmaceutical Packaging Materials and Related Announcements" in the email title.
Attachment: 1. Announcement on the release of the "Quality Management Standards for the Production of Pharmaceutical Excipients" and the "Quality Management Standards for the Production of Pharmaceutical Packaging Materials" (Draft for Comments)
2. Feedback Form
General Office of the State Drug Administration
July 16, 2024
Article Source - China Pharmaceutical Packaging Association